Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
19
GBLX Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
--
Day range:
$0.0003 - $0.5002
52-week range:
$0.0000 - $0.5002
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.26x
P/B ratio:
--
Volume:
3.3K
Avg. volume:
19.3K
1-year change:
-88%
Market cap:
$122.1K
Revenue:
--
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, GB Sciences, Inc. has -- downside to fair value with a price target of -- per share.
GBLX vs. S&P 500
-
Over the past 5 trading days, GB Sciences, Inc. has overperformed the S&P 500 by 1.35% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
GB Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GB Sciences, Inc. revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter GB Sciences, Inc. reported revenues of --.
Earnings Growth
-
GB Sciences, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter GB Sciences, Inc. reported earnings per share of -$0.00.
Enterprise value:
2.1M
EV / Invested capital:
--
Price / LTM sales:
1.26x
EV / EBIT:
--
EV / Revenue:
21.74x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.17x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | $97.2K | -- | $97.2K | |
| Gross Profit | -$78.7K | -$600 | -- | -- | -- | |
| Operating Income | -$1.6M | -$1.6M | -$848.4K | -$234K | -$66.6K | |
| EBITDA | -$1.5M | -$1.6M | -$848.4K | -$234K | -$66.6K | |
| Diluted EPS | -$0.01 | -$0.01 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.9M | $1.6M | $433.2K | $147.1K | $94.5K | |
| Total Assets | $10.2M | $6.8M | $2.8M | $147.1K | $94.5K | |
| Current Liabilities | $9M | $4.6M | $4.4M | $4.9M | $5.4M | |
| Total Liabilities | $12.7M | $5M | $4.4M | $5M | $6M | |
| Total Equity | -$2.5M | $1.8M | -$1.6M | -$4.8M | -$5.9M | |
| Total Debt | $4M | $1.8M | $1.4M | $1.5M | $2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2M | -$943.1K | -$506.4K | -$205.4K | -$124.3K | |
| Cash From Investing | -$131.7K | $320K | -- | $85K | -- | |
| Cash From Financing | $873.6K | $366.5K | $492K | $33.3K | $125K | |
| Free Cash Flow | -$2.1M | -$943.1K | -$506.4K | -$205.4K | -$124.3K | |
GBLX
Sector
Market Cap
$122.1K
$25.3M
Price % of 52-Week High
0.06%
49.41%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.6%
1-Year Price Total Return
-88%
-17.71%
Beta (5-Year)
11.460
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0003
200-day SMA
Sell
Level
$0.0003
Bollinger Bands (100)
Sell
Level
0.0004 - 0.0004
Chaikin Money Flow
Sell
Level
-57.2M
20-day SMA
Sell
Level
$0.0003
Relative Strength Index (RSI14)
Sell
Level
36.6940
ADX Line
Buy
Level
45.4837
Williams %R
Buy
Level
-99.96
50-day SMA
Sell
Level
$0.0004
MACD (12, 26)
Sell
Level
0.0000
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Sell
Level
-20.9M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.
Stock Forecast FAQ
In the current month, GBLX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GBLX average analyst price target in the past 3 months is --.
-
Where Will GB Sciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that GB Sciences, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About GB Sciences, Inc.?
Analysts are divided on their view about GB Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GB Sciences, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is GB Sciences, Inc.'s Price Target?
The price target for GB Sciences, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GBLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GB Sciences, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GBLX?
You can purchase shares of GB Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GB Sciences, Inc. shares.
-
What Is The GB Sciences, Inc. Share Price Today?
GB Sciences, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for GB Sciences, Inc.. Yesterday, GB Sciences, Inc. closed at $0.0003 per share.
-
How To Buy GB Sciences, Inc. Stock Online?
In order to purchase GB Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GBLX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBLX
Sector
P/E ratio
--
22.85x
PEG ratio
--
-0.01x
P/B ratio
--
1.78x
Price / LTM sales
1.26x
1.52x
Growth Metrics
GBLX
Sector
Revenue growth
--
3.33%
Earnings growth
--
11.64%
Revenue (5-year growth)
--
6.41%
Earnings forecast
--
-$0.20
Profitability
GBLX
Sector
Profitability FY 2023
--
$2.3M
Return on invested capital
--
-33.31%
Return on assets
--
-29.79%
Return on equity
--
-38.98%
Earnings Date
Last Earnings Date
Mar
4
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Jun
3
Balance Sheet
GBLX
Sector
Total cash
$2.3K
$24.1M
Short term investments
--
$23.8M
Total assets
$103.4K
$70.1M
Long term debt
--
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 47.98% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is down 31.47% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is down 28.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
